Ergoteles’s Invacare Corporation IVC Stock Holding History

Ergoteles’s Portfolio IVC Stock Details IVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-162,500	Closed	-$208K	–	2180
2022 Q2	$208K	Buy	+162,500	New	+$214K	0.01%	1307

Other funds holding IVC

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RCM

Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AGAM

Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Ergoteles's IVC Position: Q3 2022 in Review

Ergoteles sold out of Invacare Corporation (IVC) in Q3 2022, closing a stake of 162,500 shares — an estimated $208K sold.

Ergoteles first reported a position in IVC in Q2 2022 and held it in 1 quarter. The position peaked at $208K in Q2 2022. 72 funds tracked by Wall St. Rank hold IVC as of Q3 2022.

Ergoteles reported no remaining Invacare Corporation position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 162,500 Invacare Corporation shares in Q3 2022, an estimated $208K.
Ergoteles first reported a position in Invacare Corporation in Q2 2022 and held it in 1 quarter.
Ergoteles's Invacare Corporation position peaked at $208K in Q2 2022.
72 funds tracked by Wall St. Rank held Invacare Corporation as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.